Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Picco

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Human Mutation|January 19, 2012
Transcriptional hallmarks of Noonan syndrome and Noonan-like syndrome with loose anagen hairGiovanni Battista Ferrero, Gabriele Picco, Giuseppina Baldassarre, et al.
Cell Reports. Medicine|January 21, 2026
CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistanceAlex Watterson, Gabriele Picco, Vivien Veninga, et al.
Oncotarget|January 5, 2017
The RNA-binding protein ESRP1 promotes human colorectal cancer progressionSharmila Fagoonee, Gabriele Picco, Francesca Orso, et al.
Genome Biology|January 22, 2021
Minimal genome-wide human CRISPR-Cas9 libraryEmanuel Gonçalves, Mark Thomas, Fiona M Behan, et al.
Nature Communications|May 1, 2015
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targetsEnzo Medico, Mariangela Russo, Gabriele Picco, et al.
Nucleic Acids Research|March 14, 2026
Multiplexed TrAEL-seq captures DNA replication dynamics in mammalian cellsNeesha Kara, Laura Biggins, Alex Whale, et al.
Nature Communications|May 18, 2019
Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screeningGabriele Picco, Elisabeth D Chen, Luz Garcia Alonso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal CancerLuca Lazzari, Giorgio Corti, Gabriele Picco, et al.
Cancer Cell|January 20, 2023
Base editing screens map mutations affecting interferon-γ signaling in cancerMatthew A Coelho, Sarah Cooper, Magdalena E Strauss, et al.
Nature Genetics|October 18, 2024
Base editing screens define the genetic landscape of cancer drug resistance mechanismsMatthew A Coelho, Magdalena E Strauss, Alex Watterson, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Human Mutation|January 19, 2012
Transcriptional hallmarks of Noonan syndrome and Noonan-like syndrome with loose anagen hairGiovanni Battista Ferrero, Gabriele Picco, Giuseppina Baldassarre, et al.
Cell Reports. Medicine|January 21, 2026
CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistanceAlex Watterson, Gabriele Picco, Vivien Veninga, et al.
Oncotarget|January 5, 2017
The RNA-binding protein ESRP1 promotes human colorectal cancer progressionSharmila Fagoonee, Gabriele Picco, Francesca Orso, et al.
Genome Biology|January 22, 2021
Minimal genome-wide human CRISPR-Cas9 libraryEmanuel Gonçalves, Mark Thomas, Fiona M Behan, et al.
Nature Communications|May 1, 2015
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targetsEnzo Medico, Mariangela Russo, Gabriele Picco, et al.
Nucleic Acids Research|March 14, 2026
Multiplexed TrAEL-seq captures DNA replication dynamics in mammalian cellsNeesha Kara, Laura Biggins, Alex Whale, et al.
Nature Communications|May 18, 2019
Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screeningGabriele Picco, Elisabeth D Chen, Luz Garcia Alonso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal CancerLuca Lazzari, Giorgio Corti, Gabriele Picco, et al.
Cancer Cell|January 20, 2023
Base editing screens map mutations affecting interferon-γ signaling in cancerMatthew A Coelho, Sarah Cooper, Magdalena E Strauss, et al.
Nature Genetics|October 18, 2024
Base editing screens define the genetic landscape of cancer drug resistance mechanismsMatthew A Coelho, Magdalena E Strauss, Alex Watterson, et al.
Pageof 3